Global Pen Needles Market - 2024-2031

Global Pen Needles Market - 2024-2031

Global Pen Needles Market reached US$ 3.5 billion in 2023 and is expected to reach US$ 8.5 billion by 2031, growing with a CAGR of 11.8% during the forecast period 2024-2031.

The global pen needles market witnessed rise in demand as an increasing number of diabetes patients in which insulins are commonly used. Manufacturers introduce various innovative features such as ultra-thin needles, enhanced safety mechanisms and improved injection techniques.

Pen needles offer a convenient way for patients to administer their insulin doses without the need for any healthcare professionals. The increase in the trend towards self-care and self-management of diabetes has led to an increase demand for pen needles. The advancements improved the convenience and safety of using pen needles, which makes them more comfortable to use by patients.

North America is among the growing regions in the global pen needles market and covers a large area of the market due to its rise in medical facilities and high adoption of medical technologies. The region has witnessed increasing diabetes patients and a growing population drives the demand for the market. Government in these region adapts various initiatives to create awareness about the advancement that pen needles market offers.

Continuous growth in technology is witnessed in the pen needles market. Asia-Pacific witnessed the highest growth and the population is comparatively high compared to other regions. China, Japan and India witnessed major growth, as consumption of pen needles increased in these countries. For instance, on, 9 Sept 2022, Terumo India a global leader in the medical industry announced the launch of FineGlide for patients who requires insuline injections.

Dynamics

Growing Prevalence of Chronic Diseases

Chronic diseases such as diabetes, cardiovascular disease and cancer significantly increased. Thus increasing demand of pen needle market. The diseases require regular administration of drugs, which is now typically done using pen injectors. Pen injectors have emerged as the norm for injectable drug delivery structures because of the reality that they are easy to apply and may be administered directly by the affected person without any external assistance.

For instance, on 14 Nov 2018, HMD launches Dispovan pen needle insulin for diabetic patients, India witnessed 74 million people suffering from diabetics. Hindustan syringes and medical devices is a leading manufacture of disposable syringes and launched its dispovan insulin needles this advancement will boost the growth of pen needles market.

Diabetes requires regular insulin administration to maintain blood sugar levels. . Smart insulin pens offer features such as dose tracking, reminders and connectivity to smartphone apps, which help individuals stay on track with their insulin regimen. By promoting medication adherence, smart insulin pens contribute to better disease management and improved health outcomes.

For instance, 14 March 2023, on Smart insulin pens are reusable injector pens that help individuals with diabetes manage their condition more easily. The pens work alongside a smartphone app, which simplifies the process of calculating blood sugar levels, insulin dosage and meal sizes. By automating the maths involved in diabetes management, smart insulin pens alleviate some of the challenges faced by individuals experiencing diabetes symptoms.

Preference for Alternative Modes of Drug Delivery

Some consumers have a fear or aversion to needles that leads them to seek alternative methods of drug delivery. It can include technologies such as insulin pumps, inhalers or oral medications. The availability of these alternative options can impact the demand for pen needles, particularly among individuals who prioritize needle-free administration.

Ongoing advancements in drug delivery technologies may introduce new and more convenient options for insulin administration. For example, researchers are exploring the use of microneedle patches, implantable devices and inhalable insulin formulations. The alternative technologies prove to be more user-friendly, efficient these will boost the growth of the market.

Pen needles are generally more affordable than alternative drug delivery devices like insulin pumps, the overall cost of diabetes management can still be a significant factor for individuals. Factors such as insurance coverage and financial situations, some patients go for alternative methods that offer cost savings or better long-term value.

For instance, Researchers found a plant-based insulin-regulated system that contains three peptides. In plant-based insulin, plant cell protect insulines from acids before materials brokes into microbes. Researchers explored these plant based insuline in various aspects such genetically enegineering plants that produce plant-based protein used as insulin-like compound.

Limitations of Pen Needles in Insulin Administration

Pen needles are available in different lengths and sizes, in which ranging starts from 4mm to 8mm. The appropriate needle length depends on factors such as body size, subcutaneous fat thickness and individual preferences. However, individuals with thicker subcutaneous fat may find it challenging to effectively inject insulin with shorter needle lengths, as the insulin may not reach the desired tissue depth.

It is essential to rotate injection sites to avoid lipohypertrophy and ensure consistent insulin absorption. However, using the same injection sites repeatedly can lead to scar tissue formation and inconsistent insulin absorption. Some individuals may find it difficult to consistently rotate injection sites due to limited areas available.

Pen needles provide accurate dose delivery, but human error in dose measurement can still occur. It is crucial for individuals to carefully follow instructions for dosing and to double-check the dosage before injection. Mishandling or incorrect measurement can lead to over- or under-dosing, potentially impacting blood sugar control.

Disposing of used pen needles safely is important to prevent accidental needlestick injuries and contamination. Proper disposal options may not always be readily available, particularly when traveling or in public settings. It requires responsible disposal practices to ensure the safety of individuals and the community.

Segment Analysis

The global pen needles market is segmented based on product, length, therapy, end-user and region.

Rising Safety Pen Needles Demand for Reducing Risk Factors

Safety pen needles are specifically designed to reduce the risk of NSIs and protect both patients and healthcare professionals. The rising number of individuals diagnosed with diabetes has significantly increased the demand for insulin administration devices. As more individuals require insulin therapy, the need for safe and effective needle options becomes critical.

For instance, 27 Jun 2023, Tracey sainsbury discuss that how diabetes is increasing, In 2010 EU directives introduced safety pens. Safety pen needles in insulin administration is crucial for patient safety and the prevention of needlestick injuries. Safety pen needles come in two types: active and passive. Active safety devices show the needle throughout the injection process, requiring the user to manually activate the safety mechanism. Passive safety devices cover the needle before and after the injection, but it may obstruct the visibility of the needle.

Impact of Pen Needles in Hospital

The compact and portable design of pen needles makes them suitable for use in hospitals where mobility and space are often limited. The simplicity of pen needle usage allows for quick and accurate insulin administration, which ensures effective diabetes management for patients. The factors lead to an increase in the growth of needle markets from the hospital sector.

The prevalence of diabetes among patients who were hospitalized witnessed 12% to 26%. A study found that around 2000 patients were diagnosed with hyperglycemia at the time of hospital admission. As insulin pens are cost-effective when compared to traditional injections, so this factor makes them the preferred choice for hospitals.

Geographical Penetration

North American Manages Diabetes with Pen Needle Market

The North American pen needles market has witnessed significant growth because the rise in diabetic patients created an alarming situation in the nation, a report by national diabetes statistics that the diabetes case rise up to 37.3 million. The region has carbonated drinks and foods that have high sugar consumption these factors increase diabetes which leads to an increase in the pen needles market.

For instance, on 28 Dec 2022, research conducted by JAMA open network finds that consumers with diabetes are still experiencing increments in blood sugar levels. For managing insulin therapy patients are commonly using insulin pens that provide more convenient options compared to syringes. Pen needles ensure safety and minimize the risk of infections.

Rapid Growth of Pen Needles Due to Increasing Population

Asia-Pacific has a major growth rate in the consumption of pen needles market. Countries like China, Japan and India witnessed increases in demand due to urbanization and growing population leading to increasing consumption of pen needles in these countries. The region heavily invested in healthcare infrastructure, including medical facilities and services. The enhances the availability and distribution of pen needles that, includes hospitals, clinics and pharmacies.

For instance, on 10 Jul 2023, According to the international diabetes federation the adult population witnessed 10.5% of people having diabetes, due to their living conditions. Around 42.5% of people suffer from diabetes in Delhi and every third person in the house, these factors increase the use of pen needle insulins as they are easy to handle.

COVID-19 Impact Analysis

The pandemic highlighted the importance of chronic health conditions, including diabetes. As individuals with diabetes are considered at higher risk for COVID-19 infection, there has been a growing emphasis on effective diabetes management, including insulin administration using pen needles.

The government-imposed lockdowns and restrictions on the movement and minimized hospitals because of their chance to affected by infection, many individuals have transitioned to home-based care. The shift has led to an increased demand for pen needles, as they are easy to use at home and allow for self-administration of insulin.

The pandemic has disrupted global supply chains, that affect the production and distribution of medical devices, including pen needles. Manufacturers have faced challenges in sourcing raw materials and maintaining production levels that lead to temporary shortages in some regions. The factors affect the growth of the pen needles market.

During a pandemic, there has been an increased focus on infection control and needlestick injuries. The has led to a higher demand for safety pen needles, which incorporate safety mechanisms to reduce the risk of accidental needlestick injuries and enhance patient and healthcare provider safety.

Scope

By Product
• Standard Pen Needles
• Safety Pen Needles

By Length
• 4 mm
• 5 mm
• 6 mm
• 8 mm
• 10 mm
• 12 mm

By Therapy
• Insulin Therapy
• Glucagon-Like Peptide-1
• Growth Hormone Therapy
• Other Therapies

By End-User
• Hospitals
• Diagnostic Centers
• Ambulatory Surgery Centers
• Others

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
UK
France
Italy
Russia
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
• Middle East and Africa

Key Developments
• On 9 May 2022, Roche Diabetes launches ACCU-Fine pen needles for painless delivery of insulin, which includes a 33G 4mm variant. It have main three key features that ensure comfort to consumer and easy to use.
• On 25 May 2022, Owen Mumford announces that the safety pen needle will join unifine safe control brand. The provides safety and control and also protects from needlestick injuries.
• On 4 Nov 2022, Walgreens announces its partnership which expands access to complimentary diabetes. Walgreens aims to contribute to better disease management and improved health outcomes for the diabetes community.

Competitive Landscape

The major global players include Becton, Dickinson and Company, Novo Nordisk A/S, B. Braun Melsungen AG, Owen Mumford, Terumo Corporation, Nipro Corporation, Allison Medical, AdvaCare Pharma, Berpu Medical Technology, Trividia Health.

Why Purchase the Report?
• To visualize the global pen needles market segmentation based on product, length, therapy, end-user and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of Pen Needles market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.

The global pen needles market report would provide approximately 69 tables, 71 figures and 206 Pages.

Target Audience 2024
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies